Product Description: IONIS-MAPTRx sodium is the first Tau-lowering antisense oligonucleotide (ASO). IONIS-MAPTRx sodium has the potential for the research of Alzheimer Disease[1].
Applications: Neuroscience-Neurodegeneration
Formula: N/A
References: [1]Laurence Mignon, et al. Design of the First-in-Human Study of IONIS-MAPTRx, a Tau-lowering Antisense Oligonucleotide, in Patients With Alzheimer Disease (S2.006). Neurology Apr 2018, 90 (15 Supplement) S2.006.
Molecular Weight: 7595.80
Compound Purity: 91.82
Research Area: Neurological Disease
Solubility: 10 mM in H2O
Target: Tau Protein